Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Hanseeuw

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
JAMA Network Open|August 29, 2024
Change in Depressive Symptoms and Longitudinal Regional Amyloid Accumulation in Unimpaired Older AdultsCatherine E Munro, Michelle Farrell, Bernard Hanseeuw, et al.
Molecular Psychiatry|September 30, 2021
Association of cortical microstructure with amyloid-β and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adultsElena Rodriguez-Vieitez, Victor Montal, Jorge Sepulcre, et al.
Journal of Alzheimer'S Disease : JAD|April 6, 2026
Baseline cortical amyloid-β levels are associated with subsequent study-partner-rated apathy in community-dwelling older adultsCatherine E Munro, Jacqueline Beltran, Phebe Palmer, et al.
Science Advances|September 14, 2020
Unmasking selective path integration deficits in Alzheimer's disease risk carriersAnne Bierbrauer, Lukas Kunz, Carlos A Gomes, et al.
Journal of Alzheimer'S Disease : JAD|July 30, 2025
Neurodegenerative plasma biomarkers for prediction of hippocampal atrophy in older adults with suspected Alzheimer's disease in Kinshasa, Democratic Republic of CongoJean Ikanga, Kharine Jean, Priscilla Medina, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2025
Alzheimer's disease and its co-pathologies: Implications for hippocampal degeneration, cognitive decline, and the role of APOE ε4Klara Gawor, Sam Verrept, Geethika Arekatla, et al.
Journal of Neurology|August 1, 2020
Immune-mediated neurological syndromes in SARS-CoV-2-infected patientsAntoine Guilmot, Sofia Maldonado Slootjes, Amina Sellimi, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Neurodegenerative Plasma Biomarkers for Prediction of Hippocampal Atrophy in Older Adults with Suspected Alzheimer's Disease in Kinshasa, Democratic Republic of CongoJean Ikanga, Kharine Jean, Priscilla Medina, et al.
Neurology|August 15, 2022
A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET ImagingJulien Dumurgier, Séverine Sabia, Henrik Zetterberg, et al.
Journal of Alzheimer'S Disease : JAD|May 22, 2018
A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER)Ellis Niemantsverdriet, Annemie Ribbens, Christine Bastin, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
JAMA Network Open|August 29, 2024
Change in Depressive Symptoms and Longitudinal Regional Amyloid Accumulation in Unimpaired Older AdultsCatherine E Munro, Michelle Farrell, Bernard Hanseeuw, et al.
Molecular Psychiatry|September 30, 2021
Association of cortical microstructure with amyloid-β and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adultsElena Rodriguez-Vieitez, Victor Montal, Jorge Sepulcre, et al.
Journal of Alzheimer'S Disease : JAD|April 6, 2026
Baseline cortical amyloid-β levels are associated with subsequent study-partner-rated apathy in community-dwelling older adultsCatherine E Munro, Jacqueline Beltran, Phebe Palmer, et al.
Science Advances|September 14, 2020
Unmasking selective path integration deficits in Alzheimer's disease risk carriersAnne Bierbrauer, Lukas Kunz, Carlos A Gomes, et al.
Journal of Alzheimer'S Disease : JAD|July 30, 2025
Neurodegenerative plasma biomarkers for prediction of hippocampal atrophy in older adults with suspected Alzheimer's disease in Kinshasa, Democratic Republic of CongoJean Ikanga, Kharine Jean, Priscilla Medina, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2025
Alzheimer's disease and its co-pathologies: Implications for hippocampal degeneration, cognitive decline, and the role of APOE ε4Klara Gawor, Sam Verrept, Geethika Arekatla, et al.
Journal of Neurology|August 1, 2020
Immune-mediated neurological syndromes in SARS-CoV-2-infected patientsAntoine Guilmot, Sofia Maldonado Slootjes, Amina Sellimi, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Neurodegenerative Plasma Biomarkers for Prediction of Hippocampal Atrophy in Older Adults with Suspected Alzheimer's Disease in Kinshasa, Democratic Republic of CongoJean Ikanga, Kharine Jean, Priscilla Medina, et al.
Neurology|August 15, 2022
A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET ImagingJulien Dumurgier, Séverine Sabia, Henrik Zetterberg, et al.
Journal of Alzheimer'S Disease : JAD|May 22, 2018
A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER)Ellis Niemantsverdriet, Annemie Ribbens, Christine Bastin, et al.
Pageof 9